European Markets For Diabetes Monitoring, Treatment And Drug Delivery

NEW YORK, Feb. 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

European Markets for Diabetes Monitoring, Treatment and Drug Delivery

http://www.reportlinker.com/p01093084/European-Markets-for-Diabetes-Monitoring-Treatment-and-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

 

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

 

Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

 

Report Contents:

- Competitor Analysis

- Identified Strategic Opportunities

- Market Overview by Segment & Country

- Trend Analysis by Segment & Country

- Market Drivers & Limiters

- Mergers & Acquisitions

- Customer Feedback and Market Monitoring

 

Main Segments Included:

- Traditional blood glucose monitoring

- Blood glucose meters

- Blood glucose test strips

- Lancets and lancing devices

- Insulin

- Insulin syringes

- Insulin pens

- Insulin pumps

- Artificial pancreas

 

 

Companies Listed in Report:

- Sanofi

- Johnson & Johnson

- Eli Lilly

1 2 3 4 Next › Last »